The results, obtained in this work, also confirmed by other researchers, with regard to decreased IGFBP-1 in babies born to mothers with GDM, can be explained by hyperglycemia and an increased insulin concentration in the fetus, which inhibits the production of IGFBP-1 in the liver. Here, IGFBP1 is linked to Hyperglycemia.